Filtered By:
Source: Journal of Thoracic Disease
Condition: Heart Failure
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 134 results found since Jan 2013.
ELABELA acts as a protective biomarker in patients with atrial fibrillation
CONCLUSIONS: Expression of ELA showed a protective role in AF patients. The ELA level was negatively correlated with BNP levels, which has been shown to predict a high risk of HF independently and consistently. Additionally, lower levels of ELA were associated with a high risk of AF and HF in patients with arrhythmia.KEYWORDS: ELABELA (ELA); matrix metalloproteinase-9 (MMP-9); tissue inhibitor of metalloproteinase-1 (TIMP-1); atrial fibrillation (AF); brain natriuretic peptide (BNP).PMID:35070372 | PMC:PMC8743407 | DOI:10.21037/jtd-21-1728
Source: Journal of Thoracic Disease - January 24, 2022 Category: Respiratory Medicine Authors: Chunhong Cui Hongmei Zhou Jin Xu Source Type: research
